Infertility Treatment Devices Market Size, Share, Growth, Trends, and Global Industry Analysis: By Product Type (Imaging Systems, Equipment, Microscopes, Incubators, Gas Analysers, Laser Systems, Sperm Analyzer Systems, Ovum Aspiration Pumps, Micromanipulators System, Media & Consumables and Accessories), By Procedure (In Vitro Fertilization, Surrogacy, Artificial Insemination, Intrauterine Insemination, Intracervical Insemination, Intratubal Insemination, Assisted Reproductive Technology, Intracytoplasmic morphologically-selected sperm injection (IMSI), Gamete Donation, Intracytoplasmic Sperm Injection (ICSI), Fertility Surgery, Laparoscopy, Hysteroscopy, Myomectomy, Laparotomy, Tubal Ligation Reversal, Varicocelectomy, Laparoscopy, Hysteroscopy, Myomectomy, Laparotomy, Tubal Ligation Reversal, Microsurgical Reconstruction, Vasovasostomy, Vasoepididymostomy and Others), By Patient (Female Infertility Treatment and Male Infertility Treatment), By End User (Fertility Centres, Hospitals & Surgical Clinics and Research Institutes) and Region Forecast 2019-2030  

Infertility Treatment Devices Market size was valued at US$ 10,573.6 million in 2023 and is poised to grow at a CAGR of 7.5% from 2024 to 2030. Infertility Treatment Devices are also known as the assisted reproductive technologies (ART), by the American Centre for Disease Control (CDC), are any fertility-related treatments in which eggs or embryos are manipulated. Procedures where only sperm are manipulated like intrauterine insemination, are not considered under this definition. The key factors driving the market are significant variations in the lifestyle which subsidize to the rise in infertility and the prevalence of conditions like polycystic ovary syndrome. Consequently, a constant rise in the incidence of infertility in both sexes is anticipated to drive the infertility devices market over the forecast period.  For instance, according a research study 2022, it was stated that South Korea disclosed the greatest decline in the fertility rate among the entire OECD economies over the last 3 decades.

The article also specified that the Korean government documented the importance of healthy conceiving and childbirth under these situation and implemented policies to increase the less fertility rate and aid childbirth at unconventional maternal by instigating 'The Fourth Basic Plan on Low Fertility and Aging Society' in 2021. In future, a less fertility rate would rise the demand for in-vitro fertilization and will upsurge demand for the market growth in the future years. Moreover, the collaborations between the fertility centres and market players are anticipated drive the market over the upcoming years. However, the challenges associated with the market are high cost associated with the devices, the risk of ectopic doubles, risk of having multiple births (twins, triplets or more), hot flushes, feeling irritable, headaches, fatigue, restlessness, ovarian hyper stimulation syndrome remains the substantial barriers that hampers the demand for the growth of the market in the forecast period. However, the key opportunities associated with the infertility treatment devices are technological advancements in the infertility treatment devices, growing demand for the IVF and ICSI, favourable government polies for healthy pregnancy generates lucrative opportunities for the infertility treatment devices in the forecast period.  

Key Developments

• In July 2022, Cellink, collaborated with Spermosens, Malmö University, and Saint Louis University (SLU) to progress a diagnostic device to ascertain male infertility.